Chemical and Biomolecular Engineering - Theses
Permanent URI for this collection
Search Results
1 - 1 of 1
-
ItemEnzyme-responsive nanomaterials for the delivery of antimicrobial peptides( 2023-10)The rate of resistance to antibiotics that are commonly used in the clinic is escalating rapidly, surpassing the introduction of new antimicrobial drugs. To address this problem, alternative strategies are being explored, such as the re-evaluation of antibiotics, that have not yet gained widespread clinical application. Antimicrobial peptides (AMPs) represent one of those antibiotics, offering remarkable antimicrobial efficacy against various pathogens. However, in clinical settings, AMPs are typically considered a last-resort option due to their off-target effects and poor stability in-vivo resulting from their cationic and amphiphilic peptide nature. Therefore, most of current strategies addressing these limitations focus primarily on the control and shielding of the cationic charge and the amphiphilic nature of AMPs. These can potentially be achieved through encapsulation of AMPs inside stimuli-responsive polyelectrolyte complexes (PECs) by combining the cationic drug with anionic polyelectrolytes. Stimuli-responsive polymers can be employed as encapsulation materials in PECs to design systems that activate drug release in response to specific changes encountered during microbial infection, such as variations in pH, enzyme activity, or temperature. The overarching aim of this Thesis was to explore the creation of PECs capable of encapsulating the clinically approved antimicrobial peptide, Polymyxin B and its subsequent enzyme-induced release. In Chapters 2 and 3, the aims were: Firstly, to synthesize anionic and helical polymers incorporating enzyme-degradable peptide side chains (Aim 1.1), followed by evaluation of the degradation properties of these polymers in response to the enzyme released by gram-negative bacterium Pseudomonas aeruginosa (Aim 1.2). In Chapter 4, the first objective (Aim 1.3) was to assemble Polymyxin B and the anionic enzyme-degradable polymers into PECs. The next objective (Aim 1.4 ) involved investigating the P. aeruginosa-induced drug release from these PECs, while Aim 1.5 focused on assessing the antimicrobial activity of the developed PECs against P. aeruginosa strains. Chapter 1 provides a review of the current developments in the field of the stimuli- responsive delivery of AMPs using polyelectrolyte complexes. Chapters 2 and 3 discuss the synthesis of polymers with poly(methacrylamide) and poly(acetylene) backbones respectively coupled to enzyme-degradable peptide side chains. Of the synthesized materials, two poly(methacrylamide) polymers from Chapter 2 were found to be the most effective in terms of degradation by the enzyme released by P.aeruginosa, while none of the synthesized acetylene-containing peptides from Chapter 3 polymerized. Subsequently, the poly(methacrylamide) polymer with the highest multivalency was used to form PECs with Polymyxin B in Chapter 4. Eight different formulations of PECs were created, with one being the most optimized in terms of encapsulation efficacy and physiological stability. The stability of the particles was further improved by the addition of Tannic Acid, which acted as a protective coating and a cross-linker. The Thesis then evaluated the ability of the PECs to release Polymyxin B under enzymatic degradation. Finally, the preliminary evaluation of the antimicrobial activity of the PECs against various P.aeruginosa strains were presented.